Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment

Marine Drugs

Luc J. Martin¹ 

[1] Biology Department, Université de Moncton, Moncton, NB E1A 3E9, Canada; E-Mail

关键词: fucoxanthin;    fucoxanthinol;    viability;    apoptosis;    cancer;   

DOI  :  10.3390/md13084784

来源: mdpi

【 摘 要 】

Fucoxanthin is a carotenoid present in the chloroplasts of brown seaweeds. When ingested, it is metabolized mainly to fucoxanthinol by digestive enzymes of the gastrointestinal tract. These compounds have been shown to have many beneficial health effects, including anti-mutagenic, anti-diabetic, anti-obesity, anti-inflammatory and anti-neoplastic actions. In every cancer tested, modulatory actions of fucoxanthinol on viability, cell-cycle arrest, apoptosis and members of the NF-κB pathway were more pronounced than that of fucoxanthin. Anti-proliferative and cancer preventing influences of fucoxanthin and fucoxanthinol are mediated through different signalling pathways, including the caspases, Bcl-2 proteins, MAPK, PI3K/Akt, JAK/STAT, AP-1, GADD45, and several other molecules that are involved in cell cycle arrest, apoptosis, anti-angiogenesis or inhibition of metastasis. In this review, we address the mechanisms of action of fucoxanthin and fucoxanthinol according to different types of cancers. Current findings suggest that these compounds could be effective for treatment and/or prevention of cancer development and aggressiveness.

【 授权许可】

CC BY   
© 2015 by the authors; licensee MDPI, Basel, Switzerland.